Search

Your search keyword '"Park, Jin-woo"' showing total 1,346 results
Start Over Author "Park, Jin-woo" Database Unpaywall
1,346 results on '"Park, Jin-woo"'

3. Supplementary Figure S17 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

4. Supplementary Figure S19 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

5. Supplementary Figure S15 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

6. Supplementary Figure S12 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

7. Supplementary Figure S6 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

8. Supplementary Figure S20 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

9. Supplementary Figure S4 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

10. Supplementary Figure S18 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

11. Supplementary Figure S21 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

12. Supplementary Figure S21 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

13. Data from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

14. Supplementary Figure S17 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

15. Supplementary Figure S14 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

16. Supplementary Figure S12 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

17. Supplementary Figure S1 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

18. Supplementary Table S2 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

19. Supplementary Figure S5 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

20. Supplementary Figure S13 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

21. Supplementary Figure S10 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

22. Supplementary Figure S8 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

23. Supplementary Table S4 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

24. Supplementary Figure S2 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

25. Supplementary Figure S11 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

26. Supplementary Figure S14 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

27. Supplementary Table S2 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

28. Supplementary Figure S16 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

29. Supplementary Figure S4 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

30. Supplementary Figure S7 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

31. Supplementary Figure S11 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

32. Supplementary Figure S6 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

33. Supplementary Figure S19 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

34. Supplementary Figure S5 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

35. Supplementary Figure S9 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

36. Supplementary Table S4 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

37. Supplementary Figure S18 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

38. Supplementary Figure S9 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

39. Supplementary Figure S3 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

40. Supplementary Table S1 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

41. Supplementary Figure S20 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

42. Supplementary Table S3 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

43. Supplementary Figure S1 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

44. Supplementary Figure S13 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

45. Supplementary Table S3 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

46. Supplementary Figure S2 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

47. Supplementary Table S1 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

48. Supplementary Figure S3 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

49. Supplementary Figure S8 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

50. Supplementary Figure S10 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Author

Kim, Chang Gon, primary, Hong, Min Hee, primary, Kim, Dahee, primary, Lee, Brian Hyohyoung, primary, Kim, Hyunwook, primary, Ock, Chan-Young, primary, Kelly, Geoffrey, primary, Bang, Yoon Ji, primary, Kim, Gamin, primary, Lee, Jung Eun, primary, Kim, Chaeyeon, primary, Kim, Se-Heon, primary, Hong, Hyun Jun, primary, Park, Young Min, primary, Sim, Nam Suk, primary, Park, Heejung, primary, Park, Jin Woo, primary, Lee, Chang Geol, primary, Kim, Kyung Hwan, primary, Park, Goeun, primary, Jung, Inkyung, primary, Han, Dawoon, primary, Kim, Jong Hoon, primary, Cha, Junha, primary, Lee, Insuk, primary, Kang, Mingu, primary, Song, Heon, primary, Oum, Chiyoon, primary, Kim, Seulki, primary, Kim, Sukjun, primary, Lim, Yoojoo, primary, Kim-Schulze, Seunghee, primary, Merad, Miriam, primary, Yoon, Sun Och, primary, Kim, Hyun Je, primary, Koh, Yoon Woo, primary, and Kim, Hye Ryun, primary

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results